10.23
price up icon3.65%   0.36
after-market Handel nachbörslich: 10.23
loading
Schlusskurs vom Vortag:
$9.87
Offen:
$9.88
24-Stunden-Volumen:
713.69K
Relative Volume:
0.66
Marktkapitalisierung:
$1.08B
Einnahmen:
$247.00M
Nettoeinkommen (Verlust:
$-249.00M
KGV:
-3.3107
EPS:
-3.09
Netto-Cashflow:
$-267.00M
1W Leistung:
+11.80%
1M Leistung:
+18.68%
6M Leistung:
-22.26%
1J Leistung:
-31.71%
1-Tages-Spanne:
Value
$9.61
$10.24
1-Wochen-Bereich:
Value
$9.14
$10.24
52-Wochen-Spanne:
Value
$6.50
$18.98

Arcus Biosciences Inc Stock (RCUS) Company Profile

Name
Firmenname
Arcus Biosciences Inc
Name
Telefon
(510) 694-6200
Name
Adresse
3928 POINT EDEN WAY, HAYWARD, CA
Name
Mitarbeiter
674
Name
Twitter
@arcusbio
Name
Nächster Verdiensttermin
2024-12-06
Name
Neueste SEC-Einreichungen
Name
RCUS's Discussions on Twitter

Vergleichen Sie RCUS mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
RCUS
Arcus Biosciences Inc
10.23 1.05B 247.00M -249.00M -267.00M -3.09
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
469.65 121.28B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
563.10 60.96B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.81 42.77B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.99 36.21B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
291.47 32.08B 3.81B -644.79M -669.77M -6.24

Arcus Biosciences Inc Stock (RCUS) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-02-26 Hochstufung H.C. Wainwright Neutral → Buy
2024-10-21 Eingeleitet H.C. Wainwright Neutral
2024-10-08 Eingeleitet Wells Fargo Overweight
2022-11-18 Eingeleitet BofA Securities Neutral
2022-10-11 Eingeleitet Morgan Stanley Overweight
2021-10-15 Fortgesetzt BTIG Research Buy
2020-11-24 Eingeleitet Berenberg Buy
2020-11-23 Eingeleitet Evercore ISI Outperform
2020-04-03 Eingeleitet Cantor Fitzgerald Overweight
2020-03-04 Eingeleitet Barclays Overweight
2019-11-12 Eingeleitet SunTrust Buy
2019-09-27 Eingeleitet Mizuho Buy
2019-05-24 Fortgesetzt Citigroup Buy
2018-10-09 Eingeleitet Wedbush Outperform
2018-04-09 Eingeleitet Citigroup Buy
2018-04-09 Eingeleitet Goldman Neutral
2018-04-09 Eingeleitet Leerink Partners Outperform
Alle ansehen

Arcus Biosciences Inc Aktie (RCUS) Neueste Nachrichten

pulisher
Jul 25, 2025

What drives Arcus Biosciences Inc. stock priceExplosive earnings growth - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Arcus Biosciences Inc. Stock Analysis and ForecastMarket-beating performance - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

What analysts say about Arcus Biosciences Inc. stockRapidly growing investment returns - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 24, 2025

Arcus Biosciences Grants Fresh Employee Equity Awards: 4,200 Options Plus RSUs Revealed - Stock Titan

Jul 24, 2025
pulisher
Jul 24, 2025

Gilead and Arcus Biosciences’ Promising Lung Cancer Study: Market Implications - TipRanks

Jul 24, 2025
pulisher
Jul 23, 2025

Is Arcus Biosciences Inc. a good long term investmentConsistent high-performance stocks - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Arizona State Retirement System Purchases 5,010 Shares of Arcus Biosciences, Inc. (NYSE:RCUS) - Defense World

Jul 23, 2025
pulisher
Jul 22, 2025

Gilead and Arcus Biosciences’ Promising Phase 3 Lung Cancer Study Update - TipRanks

Jul 22, 2025
pulisher
Jul 21, 2025

Teacher Retirement System of Texas Has $143,000 Stake in Arcus Biosciences, Inc. (NYSE:RCUS) - Defense World

Jul 21, 2025
pulisher
Jul 19, 2025

Principal Financial Group Inc. Boosts Holdings in Arcus Biosciences, Inc. (NYSE:RCUS) - Defense World

Jul 19, 2025
pulisher
Jul 18, 2025

Arcus Biosciences, Inc. (NYSE:RCUS) Given Average Recommendation of “Moderate Buy” by Analysts - Defense World

Jul 18, 2025
pulisher
Jul 18, 2025

Is Arcus Biosciences Inc. stock a good hedge against inflationFree Stock Investment Discussion Area - Newser

Jul 18, 2025
pulisher
Jul 18, 2025

Trend Tracker for (RCUS) - news.stocktradersdaily.com

Jul 18, 2025
pulisher
Jul 16, 2025

how arcus biosciences inc. stock performs during market volatilityTrending Stock Alert - Newser

Jul 16, 2025
pulisher
Jul 15, 2025

How Arcus Biosciences Inc. stock performs during market volatilitySafe and Smart Investment Picks - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Arcus Biosciences Inc. stock price move sharplyFree Expert Investment Advice - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why Arcus Biosciences Inc. stock attracts strong analyst attentionElite Stock Shortlist - Newser

Jul 15, 2025
pulisher
Jul 13, 2025

Allspring Global Investments Holdings LLC Has $144,000 Stake in Arcus Biosciences, Inc. (NYSE:RCUS) - Defense World

Jul 13, 2025
pulisher
Jul 13, 2025

Allspring Global Investments Holdings LLC Purchases 6,453 Shares of Arcus Biosciences, Inc. (NYSE:RCUS) - Defense World

Jul 13, 2025
pulisher
Jul 12, 2025

Amalgamated Bank Boosts Stock Position in Arcus Biosciences, Inc. (NYSE:RCUS) - Defense World

Jul 12, 2025
pulisher
Jul 10, 2025

Arcus wins FDA orphan status for cancer drug (RCUS:NYSE) - Seeking Alpha

Jul 10, 2025
pulisher
Jul 10, 2025

Arcus Biosciences' Investigational Pancreatic Cancer Treatment Gets US FDA Orphan Drug Status - MarketScreener

Jul 10, 2025
pulisher
Jul 10, 2025

Arcus Biosciences' Quemliclustat Gets Orphan Drug Status For Pancreatic Cancer - Nasdaq

Jul 10, 2025
pulisher
Jul 10, 2025

Arcus' Pancreatic Cancer Drug Gets FDA Orphan Status as Phase 3 Trial Nears Full Enrollment - Stock Titan

Jul 10, 2025
pulisher
Jul 10, 2025

Does Arcus Biosciences (NYSE:RCUS) Have A Healthy Balance Sheet? - simplywall.st

Jul 10, 2025
pulisher
Jul 10, 2025

Arcus Biosciences' Quemliclustat Receives Orphan Drug Designatio - GuruFocus

Jul 10, 2025
pulisher
Jul 09, 2025

Arcus Biosciences Announces New Employment Inducement Grants - Business Wire

Jul 09, 2025
pulisher
Jul 01, 2025

Arcus Biosciences Presents First Postive Data for Oral Metastatic Kidney Cancer Treatment - MSN

Jul 01, 2025
pulisher
Jun 30, 2025

State of Alaska Department of Revenue Boosts Stake in Arcus Biosciences, Inc. (NYSE:RCUS) - Defense World

Jun 30, 2025
pulisher
Jun 24, 2025

Arcus Biosciences Announces New Employment Inducement Grants | R - GuruFocus

Jun 24, 2025

Finanzdaten der Arcus Biosciences Inc-Aktie (RCUS)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$23.40
price down icon 0.97%
$36.67
price up icon 0.22%
$103.95
price up icon 0.42%
$28.67
price up icon 3.99%
$115.31
price up icon 0.65%
biotechnology ONC
$291.47
price down icon 1.68%
Kapitalisierung:     |  Volumen (24h):